Varian Associates proceeds with company split
Varian Associates shareholders last month voted to approve a proposal to split the company into three separate businesses. The Palo Alto, CA, firm’s instruments and semiconductor equipment concerns will be spun off into separate companies, while the
Varian Associates shareholders last month voted to approve a proposal to split the company into three separate businesses. The Palo Alto, CA, firms instruments and semiconductor equipment concerns will be spun off into separate companies, while the remaining healthcare unit will be renamed Varian Medical Systems.
Varians board of directors proposed the split in August in an effort to focus each of its disparate businesses (SCAN 9/2/99). On Feb. 16, the company received notice from the Internal Revenue Service that the agency will allow the split to be treated as a tax-free transaction for shareholders. Two days later, Varians stockholders voted for the split.
Varian Medical Systems will continue to be listed on the New York Stock Exchange and will keep the symbol VAR. The instruments company will be called Varian, and the semiconductor business will be called Varian Semiconductor Equipment Associates.
In other news, Varian X-Ray Tube Products has introduced a series of high-performance CT x-ray tubes. The Quantum Series CT tube is based on an integral housing technology that consolidates three commonly used components of the tube: the element that generates the x-rays, the lead-lined container, and the device that helps cool the tube. Varian plans to market the tubes for use in low-cost CT systems and will begin shipping them early this year.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.
